Reply: Benefit of the shorter multidrug-resistant tuberculosis treatment regimen in California and modified eligibility criteria

European MDR-TB Database Collaboration

doi:10.1164/rccm.201705-0995LE

Reply: Benefit of the shorter multidrug-resistant tuberculosis treatment regimen in California and modified eligibility criteria

European MDR-TB Database Collaboration

Research output: Contribution to Journal › Comment / Letter to the editor › Academic

Original language	English
Pages (from-to)	1489-1490
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	196
Issue number	11
DOIs	https://doi.org/10.1164/rccm.201705-0995LE
Publication status	Published - 1 Dec 2017
Externally published	Yes

Funding

Supported by the European Commission Seventh Framework Program (FP7/2007-2013) under grant agreement FP7-223681; and the German Center for Infection Research (C.L.).

Funders	Funder number
European Commission Seventh Framework Program
FP7/2007
Deutsches Zentrum für Infektionsforschung
Seventh Framework Programme	FP7-223681

Access to Document

10.1164/rccm.201705-0995LE

Persistent URL (handle)

Persistent link

Cite this

@article{e75e002b197842a0a9783433f285e464,

title = "Reply: Benefit of the shorter multidrug-resistant tuberculosis treatment regimen in California and modified eligibility criteria",

author = "\{Van Leth\}, F. and G. G{\"u}nther and H. Hoffmann and C. Lange and \{European MDR-TB Database Collaboration\}",

year = "2017",

month = dec,

day = "1",

doi = "10.1164/rccm.201705-0995LE",

language = "English",

volume = "196",

pages = "1489--1490",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "Oxford University Press",

number = "11",

}

TY - JOUR

T1 - Reply

T2 - Benefit of the shorter multidrug-resistant tuberculosis treatment regimen in California and modified eligibility criteria

AU - Van Leth, F.

AU - Günther, G.

AU - Hoffmann, H.

AU - Lange, C.

AU - European MDR-TB Database Collaboration

PY - 2017/12/1

Y1 - 2017/12/1

UR - https://www.scopus.com/pages/publications/85038111499

UR - https://www.scopus.com/pages/publications/85038111499#tab=citedBy

U2 - 10.1164/rccm.201705-0995LE

DO - 10.1164/rccm.201705-0995LE

M3 - Comment / Letter to the editor

SN - 1073-449X

VL - 196

SP - 1489

EP - 1490

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

IS - 11

ER -

Reply: Benefit of the shorter multidrug-resistant tuberculosis treatment regimen in California and modified eligibility criteria

Funding

Access to Document

Persistent URL (handle)

Other files and links

Cite this